Cyclooxygenase-2 and prostate carcinogenesis (Q28195207)

Genetic basis and clonal evolution of human prostate cancer

Europe PubMed Central

title

Cyclooxygenase-2 and prostate carcinogenesis (English)

0 references

1 reference

Tajamul Hussain

1

0 references

Sanjay Gupta

series ordinal

2

0 references

Hasan Mukhtar

series ordinal

3

0 references

language of work or name

English

0 references

publication date

10 March 2003

0 references

published in

Cancer Letters

0 references

volume

191

0 references

issue

2

0 references

page(s)

125-35

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Target to apoptosis: A hopeful weapon for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Photolabeling of Prostaglandin Endoperoxide H Synthase-1 with 3-Trifluoro-3-(m-Iiodophenyl)diazirine as a Probe of Membrane Association and the Cyclooxygenase Active Site

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Cyclooxygenase-2: a therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

COX-2 and cancer: a new approach to an old problem

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Cyclooxygenase-1 and -2 isoenzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Prostaglandin synthase 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5'-flanking regulatory sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Prostaglandin endoperoxide synthases-1 and -2.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Role of cyclooxygenases in angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Diet, androgens, oxidative stress and prostate cancer susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Possible relationship between dietary factors and pathogenesis of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Diet and its preventive role in prostatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Dietary fat and chronic diseases: epidemiologic overview

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Dietary fat, calories, and prostate cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

A prospective study of dietary fat and risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Do diet and androgens alter prostate cancer risk via a common etiologic pathway?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Testosterone and prostate specific antigen stimulate generation of reactive oxygen species in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Expression of cyclooxygenase-2 in prostate carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

The role of cyclooxygenase-2 in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Up-Regulation of Cyclooxygenase-2 by Product-Prostaglandin E2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Role of the Bcl-2 gene family in prostate cancer progression and its implications for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

DNA oxidation induced by cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Cyclooxygenase-2 inhibitors in tumorigenesis (part I)

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

COX-2 inhibitors in cancer treatment and prevention, a recent development

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Side-effects of non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Non-steroidal anti-inflammatory drugs and prostate cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

The beneficial effects of diphosphonate and piroxicam on the osteolytic and metastatic spread of rat prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Decrease of prostaglandin E2 and 5-bromo-2'-deoxyuridine labeling but not prostate tumor development by indomethacin treatment of rats given 3,2'-dimethyl-4-aminobiphenyl and testosterone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

Prostaglandin E2 Affects the Tumor Immune Response in Prostatic Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900524-4

7 January 2021

10.1016/S0304-3835(02)00524-4

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

12618325

1 reference

Consolidated OpenCitations Corpus – April 2017